Spyre Therapeutics, Inc.(SYRE)
Biotechnology
Immunology & Autoimmune Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-03 | Sloan Sheldon Chief Medical Officer | Sale | -8,333 | -100.00%0 | $75.00 | $624,975 | View SEC filing | |
| 2026-06-03 | Turtle Cameron Chief Executive Officer | Sale | -15,000 | -2.45%597,540 | $70.43 | $1,056,486 | View SEC filing | |
| 2026-06-03 | Burrows Scott L Chief Financial Officer | Sale | -7,500 | -7.11%97,994 | $71.06 | $532,937 | View SEC filing | |
| 2026-05-08 | HENDERSON MICHAEL THOMAS Director | Sale | -80,000 | -47.45%88,606 | $74.40 | $5,952,050 | View SEC filing | |
| 2026-05-01 | Sloan Sheldon Chief Medical Officer | Sale | -78,333 | -100.00%0 | $71.50 | $5,600,701 | View SEC filing | |
| 2026-05-01 | Burrows Scott L Chief Financial Officer | Sale | -12,500 | -11.31%97,994 | $71.37 | $892,125 | View SEC filing | |
| 2026-05-01 | Turtle Cameron Chief Executive Officer | Sale | -15,000 | -2.39%612,540 | $71.37 | $1,070,507 | View SEC filing | |
| 2026-04-03 | Burrows Scott L Chief Financial Officer | Sale | -7,500 | -7.11%97,994 | $49.34 | $370,076 | View SEC filing | |
| 2026-04-03 | Turtle Cameron Chief Executive Officer | Sale | -15,000 | -2.33%627,540 | $49.33 | $739,912 | View SEC filing | |
| 2026-04-03 | Sloan Sheldon Chief Medical Officer | Sale | -7,958 | -100.00%0 | $50.00 | $397,900 | View SEC filing | |
| 2026-03-03 | Burrows Scott L Chief Financial Officer | Sale | -2,500 | -2.49%97,994 | $40.65 | $101,620 | View SEC filing | |
| 2026-03-03 | Turtle Cameron Chief Executive Officer | Sale | -15,000 | -2.28%642,540 | $42.19 | $632,866 | View SEC filing | |
| 2026-02-04 | Turtle Cameron Chief Executive Officer | Sale | -15,000 | -2.23%657,540 | $32.80 | $492,045 | View SEC filing | |
| 2026-01-06 | Turtle Cameron Chief Executive Officer | Sale | -15,000 | -2.18%671,907 | $30.68 | $460,134 | View SEC filing | |
| 2025-12-03 | Turtle Cameron Chief Executive Officer | Sale | -15,000 | -2.14%686,907 | $29.02 | $435,356 | View SEC filing | |
| 2025-11-05 | Turtle Cameron Chief Executive Officer | Sale | -45,000 | -6.02%701,907 | $23.33 | $1,049,778 | View SEC filing | |
| 2025-09-03 | Burrows Scott L Chief Financial Officer | Sale | -18,428 | -15.83%97,994 | $16.26 | $299,639 | View SEC filing | |
| 2024-11-08 | Albers Jeffrey W. Director | Sale | -6,700 | -19.67%27,360 | $36.76 | $246,313 | View SEC filing | |
| 2024-10-28 | Albers Jeffrey W. Director | Sale | -300 | -0.87%34,060 | $36.43 | $10,929 | View SEC filing | |
| 2024-09-05 | Burrows Scott L Chief Financial Officer | Sale | -18,531 | -13.73%116,422 | $28.17 | $522,074 | View SEC filing | |
| 2022-08-25 | Souza Marcio Director | Purchase | +90,000 | +100.00%90,000 | $0.56 | $50,472 | View SEC filing | |
| 2022-06-10 | Hanley Jr. Michael Conick Chief Commercial Officer | Purchase | +28,200 | +352.50%36,200 | $0.71 | $20,022 | View SEC filing | |
| 2022-03-18 | Quinn Anthony G. President & CEO | Purchase | +80,079 | +17.02%550,540 | $2.34 | $187,705 | View SEC filing | |
| 2022-03-15 | Quinn Anthony G. President & CEO | Purchase | +144,666 | +44.00%473,461 | $1.94 | $280,943 | View SEC filing | |
| 2022-03-15 | Alspaugh Jonathan Chief Financial Officer | Purchase | +75,000 | +82.99%165,372 | $2.08 | $156,000 | View SEC filing |
1-25 of 46